These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2136385

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Structural and functional consequences of an N-glycosylation mutation (HEMPAS) affecting human erythrocyte membrane glycoproteins.
    Kameh H, Landolt-Marticorena C, Charuk JH, Schachter H, Reithmeier RA.
    Biochem Cell Biol; 1998; 76(5):823-35. PubMed ID: 10353717
    [Abstract] [Full Text] [Related]

  • 6. Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II.
    Fukuda MN, Dell A, Scartezzini P.
    J Biol Chem; 1987 May 25; 262(15):7195-206. PubMed ID: 2953718
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Polylactosamines are not obligate receptors for invasion of Plasmodium falciparum malaria as shown in HEMPAS variant II-gal- erythrocytes.
    Dhume ST, Adams-Burton CR, Shumak KH, Laine RA.
    Glycobiology; 1994 Dec 25; 4(6):903-8. PubMed ID: 7734852
    [Abstract] [Full Text] [Related]

  • 11. Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS).
    Charuk JH, Tan J, Bernardini M, Haddad S, Reithmeier RA, Jaeken J, Schachter H.
    Eur J Biochem; 1995 Jun 01; 230(2):797-805. PubMed ID: 7607254
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Decreased glycosylation of band 3 and band 4.5 glycoproteins of erythrocyte membrane in congenital dyserythropoietic anaemia type II.
    Scartezzini P, Forni GL, Baldi M, Izzo C, Sansone G.
    Br J Haematol; 1982 Aug 01; 51(4):569-76. PubMed ID: 7104237
    [Abstract] [Full Text] [Related]

  • 17. Reduced deformability of erythrocytes as feature of congenital dyserythropoietic anaemia type II (HEMPAS).
    Izzo P, Spagnuolo A, Manicone A, Nazzaro P, Lauta VM.
    Clin Hemorheol Microcirc; 1999 Aug 01; 21(3-4):425-30. PubMed ID: 10711781
    [Abstract] [Full Text] [Related]

  • 18. Congenital dyserythropoietic anemia type II (CDAII/HEMPAS): where are we now?
    Denecke J, Marquardt T.
    Biochim Biophys Acta; 2009 Sep 01; 1792(9):915-20. PubMed ID: 19150496
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects.
    Iolascon A, D'Agostaro G, Perrotta S, Izzo P, Tavano R, Miraglia del Giudice B.
    Haematologica; 1996 Sep 01; 81(6):543-59. PubMed ID: 9009444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.